Brain-derived neurotrophic factor serum and plasma levels in the treatment of acute schizophrenia with olanzapine or risperidone: 6-week prospective study. (Q48215288)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Brain-derived neurotrophic factor serum and plasma levels in the treatment of acute schizophrenia with olanzapine or risperidone: 6-week prospective study.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28671000%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

Brain-derived neurotrophic factor serum and plasma levels in the treatment of acute schizophrenia with olanzapine or risperidone: 6-week prospective study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28671000%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

0 references

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28671000%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28671000%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

author name string

Suzan Kudlek Mikulic

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28671000%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

Alma Mihaljevic-Peles

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28671000%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

Maja Bajs Janovic

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28671000%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

Jasmina Grubisin

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28671000%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

Martina Kuzman Rojnic

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28671000%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

Bjanka Vuksan Cusa

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28671000%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

Zoran Bradaš

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28671000%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

Nada Božina

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28671000%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

publication date

2 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28671000%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

Nordic Journal of Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28671000%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

71

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28671000%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28671000%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

513-520

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28671000%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

Long-term outcome of patients with schizophrenia: a review

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

The neurobiology and treatment of first-episode schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

Peptide immunoreactivity in aged rat cortex and hippocampus as a function of memory and BDNF infusion.

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

Blood BDNF concentrations reflect brain-tissue BDNF levels across species

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

Brain-Derived Neurotrophic Factor/TrkB Signaling in Memory Processes

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

Transport of brain-derived neurotrophic factor across the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

Neurotrophic factors and the pathophysiology of schizophrenic psychoses

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

The role of BDNF in the pathophysiology and treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

Lower Brain-Derived Neurotropic Factor Levels in Untreated Adolescents With First-Episode Psychosis

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

Gender difference in association of cognition with BDNF in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

High-quality remission: potential benefits of the melatonergic approach for patients with major depressive disorder

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

Serum levels of brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) in depressed patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

Levels of Serum Brain-Derived Neurotrophic Factor in Schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia.

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

The influence of aripiprazole, olanzapine and enriched environment on depressant-like behavior, spatial memory dysfunction and hippocampal level of BDNF in prenatally stressed rats

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

Effects of antipsychotic drugs on the expression of synaptic proteins and dendritic outgrowth in hippocampal neuronal cultures

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

Effects of antipsychotic drugs on the expression of synapse-associated proteins in the frontal cortex of rats subjected to immobilization stress.

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

Association of serum brain-derived neurotrophic factor and duration of untreated psychosis in first-episode patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

Reduced Brain-Derived Neurotrophic Factor Serum Concentrations in Acute Schizophrenic Patients Increase During Antipsychotic Treatment

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

Increase in brain-derived neurotrophic factor in first episode psychotic patients after treatment with atypical antipsychotics

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

Effects of antipsychotics on the serum BDNF levels in schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

Nicotine dependence and serum BDNF levels in male patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

What does the PANSS mean?

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

A close correlation between plasma and serum levels of brain-derived neurotrophic factor (BDNF) in healthy volunteers

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

BDNF as a biomarker for successful treatment of mood disorders: a systematic & quantitative meta-analysis

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

Evidence for a release of brain-derived neurotrophic factor from the brain during exercise

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

The impact of age, weight and gender on BDNF levels in human platelets and plasma

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

Increase in serum brain-derived neurotrophic factor in met allele carriers of the BDNF Val66Met polymorphism is specific to males

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

A longitudinal study of alterations of hippocampal volumes and serum BDNF levels in association to atypical antipsychotics in a sample of first-episode patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

Vascular endothelial growth factor and brain-derived neurotrophic factor in quetiapine treated first-episode psychosis

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

Smoking and BDNF Val66Met polymorphism in male schizophrenia: a case-control study

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

Decreased levels of serum brain-derived neurotrophic factor in drug-naïve first-episode schizophrenia: relationship to clinical phenotypes

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

Association of biomarkers and depressive symptoms in schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

BDNF and S100B in psychotic disorders: evidence for an association with treatment responsiveness

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

Associations between serum brain-derived neurotrophic factor levels and clinical phenotypes in schizophrenia patients

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

Plasma brain-derived neurotrophic factor daily variations in men: correlation with cortisol circadian rhythm

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

Determinants of serum brain-derived neurotrophic factor

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

Serum brain-derived neurotrophic factor and clozapine daily dose in patients with schizophrenia: A positive correlation

1 reference

https://api.crossref.org/works/10.1080%2F08039488.2017.1340518

21 January 2018

Identifiers

10.1080/08039488.2017.1340518

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28671000%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28671000%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48215288&oldid=1566659699"